News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
25,192 Results
Type
Article (3695)
Company Profile (5)
Press Release (21492)
Multimedia
Podcasts (18)
Webinars (4)
Section
Business (8711)
Career Advice (39)
Deals (1219)
Drug Delivery (19)
Drug Development (4360)
Employer Resources (12)
FDA (708)
Job Trends (1063)
News (14720)
Policy (1536)
Tag
Academia (81)
Adcomms (1)
Allergies (1)
Alliances (2273)
ALS (2)
Alzheimer's disease (32)
Antibody-drug conjugate (ADC) (39)
Approvals (703)
Artificial intelligence (14)
Autoimmune disease (2)
Automation (2)
Bankruptcy (9)
Best Places to Work (846)
BIOSECURE Act (7)
Biosimilars (4)
Biotechnology (2)
Bladder cancer (8)
Brain cancer (8)
Breast cancer (42)
Cancer (309)
Cardiovascular disease (20)
Career advice (38)
Career pathing (1)
CAR-T (8)
CDC (9)
Cell therapy (17)
Cervical cancer (6)
Clinical research (3613)
Collaboration (49)
Company closure (1)
Compensation (6)
Complete response letters (4)
COVID-19 (202)
CRISPR (1)
C-suite (30)
Cystic fibrosis (2)
Data (102)
Depression (3)
Diabetes (3)
Diagnostics (90)
Diversity, equity & inclusion (3)
Drug discovery (7)
Drug pricing (28)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (2194)
Editorial (6)
Employer branding (6)
Employer resources (12)
Events (2389)
Executive appointments (70)
FDA (746)
Funding (28)
Gene editing (6)
Generative AI (2)
Gene therapy (11)
GLP-1 (68)
Government (300)
Grass and pollen (1)
Guidances (6)
Healthcare (482)
HIV (8)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (16)
Immuno-oncology (5)
Indications (1)
Infectious disease (218)
Inflammatory bowel disease (6)
Inflation Reduction Act (3)
Intellectual property (5)
Interviews (2)
IPO (367)
IRA (12)
Job creations (284)
Job search strategy (36)
Kidney cancer (4)
Labor market (1)
Layoffs (46)
Legal (401)
Liver cancer (7)
Longevity (1)
Lung cancer (79)
Lymphoma (8)
Machine learning (1)
Management (4)
Manufacturing (29)
MASH (5)
Medical device (83)
Medtech (83)
Mergers & acquisitions (865)
Metabolic disorders (24)
Multiple sclerosis (7)
Neurodegenerative disease (7)
Neuropsychiatric disorders (2)
Neuroscience (55)
NextGen: Class of 2025 (196)
Non-profit (90)
Obesity (14)
Opinion (34)
Ovarian cancer (7)
Pain (4)
Pancreatic cancer (3)
Parkinson's disease (2)
Patents (14)
Patient recruitment (4)
People (3838)
Pharmaceutical (2)
Pharmacy benefit managers (3)
Phase I (1057)
Phase II (1633)
Phase III (1491)
Pipeline (78)
Policy (44)
Postmarket research (201)
Preclinical (271)
Press Release (2)
Prostate cancer (5)
Psychedelics (4)
Radiopharmaceuticals (17)
Rare diseases (14)
Real estate (213)
Recruiting (4)
Regulatory (990)
Reports (7)
Research institute (71)
Resumes & cover letters (1)
RNA editing (1)
RSV (12)
Schizophrenia (3)
Series A (9)
Series B (7)
Sickle cell disease (2)
Special edition (5)
Spinal muscular atrophy (4)
Sponsored (2)
Startups (208)
Stomach cancer (9)
Supply chain (5)
Tariffs (15)
The Weekly (16)
Vaccines (123)
Venture capital (6)
Weight loss (17)
Women's health (2)
Worklife (1)
Date
Today (1)
Last 7 days (16)
Last 30 days (63)
Last 365 days (1050)
2025 (592)
2024 (1237)
2023 (1319)
2022 (2976)
2021 (2787)
2020 (2293)
2019 (1546)
2018 (1196)
2017 (1348)
2016 (1159)
2015 (1327)
2014 (867)
2013 (725)
2012 (785)
2011 (880)
2010 (816)
Location
Africa (64)
Alabama (4)
Alaska (1)
Arizona (2)
Asia (1473)
Australia (387)
California (136)
Canada (64)
China (53)
Colorado (2)
Connecticut (3)
Delaware (13)
Europe (4316)
Florida (36)
Georgia (2)
Illinois (7)
Indiana (1)
Japan (28)
Kentucky (1)
Maryland (23)
Massachusetts (171)
Minnesota (2)
Mississippi (1)
Missouri (3)
Nevada (1)
New Hampshire (2)
New Jersey (166)
New York (64)
North Carolina (12)
Northern California (70)
Ohio (1)
Oregon (1)
Pennsylvania (18)
Rhode Island (3)
South America (61)
Southern California (43)
Tennessee (1)
Texas (21)
United States (702)
Utah (6)
Virginia (3)
Washington D.C. (5)
Washington State (24)
West Virginia (1)
25,192 Results for "merck kgaa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
aptaTargets transferred ApTOLL to Merck KGaA, Darmstadt, Germany
ApTOLL completed a Phase 1b/2 clinical trial for acute ischemic stroke with positive results. Merck KGaA, Darmstadt, Germany, to assume clinical development and commercialization of ApTOLL.
May 22, 2025
·
1 min read
Mergers & acquisitions
Merck KGaA Moves Ahead on SpringWorks Buy for $3.9B
The transaction is expected to close in the second half of 2025. With the deal, Merck KGaA is adding to its rare disease and oncology pipelines.
April 28, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Merck KGaA Courts Cancer Biotech SpringWorks for Potential Buyout
Following an initial report from
Reuters
, Merck KGaA confirmed that it is in talks with SpringWorks for a potential acquisition, though details of its offer have yet to be revealed.
February 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business
July 1, 2025
·
5 min read
Press Releases
China’s Center for Drug Evaluation Accepts Merck KGaA, Darmstadt, Germany’s Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell Tumor
June 10, 2025
·
6 min read
Press Releases
Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business
April 28, 2025
·
9 min read
Drug Development
Merck KGaA Fails Phase III Study in Head and Neck Cancer, Scraps Trials
Merck KGaA’s drug candidate xevinapant in a late-stage trial was unable to significantly improve event-free survival in patients with locally advanced head and neck cancer.
June 25, 2024
·
2 min read
·
Tristan Manalac
BioMidwest
Gamma Biosciences Announces Sale of Mirus Bio to Merck KGaA, Darmstadt, Germany, for $600 Million
Gamma Biosciences announced that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, whereby Merck KGaA, Darmstadt, Germany, will acquire Gamma operating company Mirus Bio for $600 million in cash.
May 23, 2024
·
4 min read
M&A
Merck Makes Big Respiratory Play With $10B Acquisition of Verona
In the second biggest acquisition of the year, Merck gains the commercial COPD drug Ohtuvayre, which could help offset the loss of revenue when Keytruda’s patent expires later this decade.
July 9, 2025
·
2 min read
·
Tristan Manalac
Cancer
Arcus Kidney Cancer Drug Casdatifan Advances to Challenge Merck’s Welireg
Updated Phase I/Ib data in hand, Arcus will launch a Phase III trial as it aims to compete with Merck, whose drug secured approval for a type of kidney cancer in 2023.
June 2, 2025
·
2 min read
·
Nick Paul Taylor
1 of 2,520
Next
